UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore the credit cards that offer the best cash back rewards. Make your spending work for you.
28,278 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Fewer Gen Z adults are forming romantic relationships, a trend linked to softer social skills and new onboarding chal...
Across 460+ real-life millionaire interviews, readers gain practical, proven money strategies. This article shows how...
A New Mexico verdict against Meta and a California ruling involving Meta and YouTube mark a turning point in lawsuits...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...
Ripple has lined up a wave of partnerships with global banks in 2026, but XRP prices haven’t reflected the wins. Here...
A rapid-growth software startup markets a scrolling-based monetization model and seeks pre-IPO investors at $0.50 a s...
Cardano teams with Brazil's Olympic Committee to modernize sports administration using AI, blockchain, and IoT. ADA r...
A House committee hearing on digital asset taxation highlighted sharp divides among lawmakers on urgency and approach...
A long-remembered jab about Chrome’s prospects resurfaces as the browser landscape continues to evolve. Here’s what i...
Apple warns memory costs may squeeze margins and push pricing for the iPhone 18 cycle. Investors are weighing how you...
As July 1, 2026 nears, California’s Digital Financial Assets Law tests Ripple and other crypto operators. XRP trades ...